The prevention and treatment effect of Shenlingbaizhu Powder from the perspective of the mechanism of the occurrence of ovarian hyperstimulation syndrome
- Conditions
- Ovarian hyperstimulation syndrome
- Registration Number
- ITMCTR2200005791
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
? Patients who may develop OHSS and meet the TCM syndrome differentiation criteria of deficiency of spleen and kidney were evaluated during COH;
? For ivF-ET patients aged 20-38 years, ovulation induction is suitable for fresh embryo transfer.
? Patients who signed informed consent and agreed to participate in the clinical trial with good compliance.
If the inclusion criteria above are not met, the patient cannot be included.
? Those who have taken similar drug treatment recently and whose efficacy is difficult to judge, or have a history of drug or alcohol abuse.
? Do not want to cooperate (such as not according to the provisions of the drug and affect the curative effect of qiao break) and mental illness, cognitive disorders.
? Emergency measures must be taken if symptoms worsen.
? Allergic constitution or allergic to a certain component of the drug used in the clinical trial.
? Those who are participating in clinical trials of other drugs.
? Failing to sign the informed consent.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method vascular endothelial growth factor;inflammatory factor;
- Secondary Outcome Measures
Name Time Method